ProPhase Labs (PRPH)
(Delayed Data from NSDQ)
$2.69 USD
+0.29 (12.08%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $2.69 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (93 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 0.00 | 1.58 | 9.99 |
Current Quarter Estimate | 0.04 | -1.22 | 61.00 |
Year Ago Quarter Estimate | -0.30 | -0.07 | 54.84 |
Next Quarter Estimate | 0.09 | -1.93 | 63.00 |
Next Year Estimate | 0.48 | 12.53 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 89.80 | 20.10 | 15.67 |
Next Year | 580.00 | 15.20 | 11.34 |
Last 5 Years | -239.20 | 7.90 | 8.10 |
Next 5 Years | NA | 21.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -3.93 |
Price/Book (MRQ) | 1.04 | 1.61 |
Price/Cash Flow (MRFY) | NA | 9.71 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -146.39% | -58.89% |
Return on Equity (TTM) | -54.04% | -58.99% |
Debt to Equity (MRQ) | 0.33 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.